Table 1.
Results of 5-years follow-up n (%)
| Items | Patients |
| Refractory ascites or hydrothorax | 15 (7.2) |
| EGVB | 77 (36.8) |
| Hepatic encephalopathy | 82 (39.2) |
| Distributary channel restenosis (yr) | |
| 1 | 36 (17.2) |
| 2 | 62 (29.7) |
| 3 | 77 (36.8) |
| 4 | 95 (45.5) |
| 5 | 122 (58.4) |
| Interventional treatments | |
| RFA | 113 (54.1) |
| Once | 34 (30.1) |
| Twice | 42 (37.2) |
| Thrice or more | 37 (32.7) |
| TACE/TAE | 185 (88.5) |
| Once | 31 (16.8) |
| Twice | 42 (22.7) |
| Thrice or more | 112 (60.5) |
| Fistula embolization | 22 (10.5) |
| Once | 6 (27.3) |
| Twice | 14 (63.6) |
| Thrice or more | 2 (9.1) |
| Splenic artery embolization | 14 (6.7) |
| Once | 7 (50.0) |
| Twice | 6 (42.9) |
| Thrice or more | 1 (7.1) |
| Interventional re-treatments | 102 (48.8) |
| Twice | 62 (60.8) |
| Thrice or more | 40 (39.2) |
| Balloon angioplasty | 9 (8.8) |
| Stent angioplasty | 93 (91.2) |
EGVB: Esophageal gastric-fundus variceal bleeding; TACE: Transarterial chemoembolization; TAE: Transarterial embolization; RFA: Radiofrequency ablation.